Alternatives to Infinimmune

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

AI safety and research company building reliable, interpretable, and steerable AI systems.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Enzyme-based technology to break down alcohol in the stomach.

A vertically-integrated procurement platform for the life sciences industry.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

A global leader in clinical pharmacology and bioanalytical sciences.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

Developing novel immunotherapies and diagnostics for cancer.

A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.

A biotechnology company developing genetic therapies for rare disorders.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

Developing gene editing therapies to lower cholesterol.

A nonprofit research organization leveraging AI and biotechnology to understand and treat complex diseases.

Clinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.

AI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.

Biotechnology company developing next-generation gene therapies using a proprietary protein splicing platform.

Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.

A biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

Engineering scalable gene therapies for broader patient populations.

A University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology.

AI-native biotech company designing next-generation CAR T therapies for solid tumors.

An end-to-end imaging company providing enterprise-grade imaging and precision endpoints for clinical trials, focusing on lung and heart disease.

Advancing deupirfenidone as a potential new standard of care for Idiopathic Pulmonary Fibrosis (IPF).

Developing oral small molecule medicines for immunological and chronic diseases.

Pioneering vision restoration therapies for severe retinal degenerations.

Developing ultrasound-mediated nonviral genetic medicines.

AI-powered antibody discovery platform.

Advancing next-generation mRNA medicines.

Developing novel therapies to reverse aging and extend lifespan.

Advancing clinical stage pipeline targeting new and major neurology and neuropsychiatric disorders.

A full-stack spatial biology company.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

Developing a new class of anti-IgE therapy for multiple atopic conditions.

A biopharmaceutical company focused on developing and commercializing therapies for rare diseases.

A biotechnology ecosystem company powering the future of drug discovery and development through AI-driven platforms and integrated services.

Provides regulated, secure, and high-yield digital asset solutions for institutional and corporate treasuries.

A biotechnology company focused on developing novel enzyme-based therapies for reflux disease.

Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies.

AI biologist platform accelerating preclinical drug development by integrating biological data for smarter decisions.

Developing first-in-class oral therapy for BK polyomavirus infections.

Immunotherapy company targeting oncology and autoimmune diseases.

A biotechnology company focused on oncology drug discovery.

Developing epigenetic reprogramming drugs for age restoration.

AI platform for engineering molecular glues to create a new class of medicines.

Clinical-stage immunotherapy company developing novel treatments for cancer.

Scalable, one-time curative in-vivo gene editing therapies.

Developing small-molecule modulators of lysosomal ion channels for neurodegenerative diseases.

Clinical-stage biopharmaceutical company developing transformative, best-in-class neuropsychiatric therapies.